149 related articles for article (PubMed ID: 29444929)
21. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
22. Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?
Nandra R; Parry M; Forsberg J; Grimer R
Clin Orthop Relat Res; 2017 Jun; 475(6):1681-1689. PubMed ID: 28397168
[TBL] [Abstract][Full Text] [Related]
23. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.
Li K; Anderson G; Viallon V; Arveux P; Kvaskoff M; Fournier A; Krogh V; Tumino R; Sánchez MJ; Ardanaz E; Chirlaque MD; Agudo A; Muller DC; Smith T; Tzoulaki I; Key TJ; Bueno-de-Mesquita B; Trichopoulou A; Bamia C; Orfanos P; Kaaks R; Hüsing A; Fortner RT; Zeleniuch-Jacquotte A; Sund M; Dahm CC; Overvad K; Aune D; Weiderpass E; Romieu I; Riboli E; Gunter MJ; Dossus L; Prentice R; Ferrari P
Breast Cancer Res; 2018 Dec; 20(1):147. PubMed ID: 30509329
[TBL] [Abstract][Full Text] [Related]
24. Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer.
Ryu JM; Choi HJ; Kim I; Lee SK; Yu J; Kim JE; Kang BI; Lee JE; Nam SJ; Kim SW
Breast Cancer Res Treat; 2018 Dec; 172(3):627-636. PubMed ID: 30218195
[TBL] [Abstract][Full Text] [Related]
25. Advancement study of CancerMath model as prognostic tools for predicting Sentinel lymph node metastasis in clinically negative T1 breast cancer patients.
Massafra R; Pomarico D; Fanizzi A; Campobasso F; Didonna V; Latorre A; Nardone A; Pastena IM; Tamborra P; Lorusso V; La#Forgia D
J BUON; 2021; 26(3):720-727. PubMed ID: 34268926
[TBL] [Abstract][Full Text] [Related]
26. External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes.
Aguirre U; García-Gutiérrez S; Romero A; Domingo L; Castells X; Sala M;
J Eval Clin Pract; 2019 Oct; 25(5):873-880. PubMed ID: 30548721
[TBL] [Abstract][Full Text] [Related]
27. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
[TBL] [Abstract][Full Text] [Related]
28. Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.
Li CI; Zhang Y; Cieślik M; Wu YM; Xiao L; Cobain E; Tang MC; Cao X; Porter P; Guenthoer J; Robinson DR; Chinnaiyan AM
Clin Cancer Res; 2021 Jun; 27(11):3079-3093. PubMed ID: 33753452
[TBL] [Abstract][Full Text] [Related]
29. Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data.
Beachler DC; de Luise C; Yin R; Gangemi K; Cochetti PT; Lanes S
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):171-178. PubMed ID: 30411431
[TBL] [Abstract][Full Text] [Related]
30. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
Tang G; Shak S; Paik S; Anderson SJ; Costantino JP; Geyer CE; Mamounas EP; Wickerham DL; Wolmark N
Breast Cancer Res Treat; 2011 May; 127(1):133-42. PubMed ID: 21221771
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor expression and breast cancer mortality in a population-based prospective cohort.
Elebro K; Bendahl PO; Jernström H; Borgquist S
Breast Cancer Res Treat; 2017 Oct; 165(3):645-657. PubMed ID: 28643022
[TBL] [Abstract][Full Text] [Related]
33. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
[TBL] [Abstract][Full Text] [Related]
34. Nomogram to predict contralateral breast cancer risk in breast cancer survivors: A SEER-based study.
Tong J; Tan D; Ma J; Hu Y; Li M
Medicine (Baltimore); 2021 Nov; 100(46):e27595. PubMed ID: 34797281
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
[TBL] [Abstract][Full Text] [Related]
36. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer.
Roylance R; Endesfelder D; Gorman P; Burrell RA; Sander J; Tomlinson I; Hanby AM; Speirs V; Richardson AL; Birkbak NJ; Eklund AC; Downward J; Kschischo M; Szallasi Z; Swanton C
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2183-94. PubMed ID: 21784954
[TBL] [Abstract][Full Text] [Related]
37. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract][Full Text] [Related]
38. Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
Zhang M; Wang B; Liu N; Wang H; Zhang J; Wu L; Zhao A; Wang L; Zhao X; Yang J
BMC Cancer; 2021 May; 21(1):565. PubMed ID: 34001061
[TBL] [Abstract][Full Text] [Related]
39. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.
Martin KJ; Patrick DR; Bissell MJ; Fournier MV
PLoS One; 2008 Aug; 3(8):e2994. PubMed ID: 18714348
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
